5.09708
SKF-97541
别名:
SKF-97541, GABA B Receptor Agonist, SKF-97541, SKF 97541, CGP 35024, 3-APMPA
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C4H12NO2P
化学文摘社编号:
分子量:
137.12
MDL number:
UNSPSC Code:
12352200
NACRES:
NA.77
SMILES string
[P](=O)(O)(CCC[N+H3])C
InChI
1S/C4H12NO2P/c1-8(6,7)4-2-3-5/h2-5H2,1H3,(H,6,7)/p+1
InChI key
NHVRIDDXGZPJTJ-UHFFFAOYSA-O
assay
≥98% (TLC)
form
solid
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze, protect from light
color
white
solubility
water: 100 mM
Quality Level
General description
A highly potent agonist of GABAB receptor. Depresses excitatory postsynaptic potentials mediated by glutamate in the striatum, and hyperpolarized neurones in the substantia nigra (IC50 = 92 nM). Shown to be about 10-times more potent than baclofen (Cat. No. 505873). Induces vasodepression in pulmonary vascular bed that is modulated by an ATP-sensitive K+ channel. Induces gastric acid secretion in a dose-dependent manner (0.01 - 3 mg/kg, i.v.) in mice.
Please note that the molecular weight for this compound is batch-specific due to variable water content.
Please note that the molecular weight for this compound is batch-specific due to variable water content.
Biochem/physiol Actions
Primary Target
GABAB
GABAB
Packaging
Packaged under inert gas
Preparation Note
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Other Notes
Kaye, A.D., et al. 2004. Anesth. Analg.99, 758.
Piqueras, L., and Martinez, V. 2004. Br. J. Pharmacol.142, 1038.
Seabrook, G.R., et al. 1990. Br. J. Pharmacol.101, 949.
Piqueras, L., and Martinez, V. 2004. Br. J. Pharmacol.142, 1038.
Seabrook, G.R., et al. 1990. Br. J. Pharmacol.101, 949.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Toxicity: Standard Handling (A)
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
监管及禁止进口产品
此项目有
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持